6 Recruiting Colorectal Neoplasms Phase 3 Clinical Trials
Active phase 3 studies for colorectal neoplasms enrolling across the USA. Verify eligibility and contact site coordinators.
All Colorectal Neoplasms studiesPhase 3 Studies for Colorectal Neoplasms
🔵 Active, Not Recruiting Phase3
S0820, Adenoma and Second Primary Prevention Trial
📍 University of Alabama at Birmingham Cancer Center — Birmingham, Alabama
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase2 / Phase3
A Study of a Patient-Specific Neoantigen Vaccine in Combination With Immune Checkpoint Blockade for Patients With Metastatic Colorectal Cancer
📍 Banner MD Anderson — Gilbert, Arizona
View Study & Checklist ➔ 🟢 Recruiting Phase3
A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer
📍 Palo Verde Hematology Oncology — Glendale, Arizona
View Study & Checklist ➔ 🟢 Recruiting Phase3
Performance of SGM-101 for the Delineation of Primary and Recurrent Tumor and Metastases in Patients Undergoing Surgery for Colorectal Cancer
📍 City of Hope National Medical Center — Duarte, California
View Study & Checklist ➔ 🟢 Recruiting Phase3
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
📍 Banner MD Anderson Cancer Center — Gilbert, Arizona
View Study & Checklist ➔ 🟢 Recruiting Phase3
A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy
📍 Ironwood Cancer and Research Center — Chandler, Arizona
View Study & Checklist ➔